Skip to content

Drug interactions

Fenofibrate + Gliclazide

Severity: Minor

Fenofibrate and Gliclazide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fenofibrate improves insulin sensitivity and can modestly increase glucose lowering with sulfonylureas, with a possible risk of hypoglycemia. Fenofibrate also inhibits CYP2C9 in vitro, which could slightly increase gliclazide exposure.

What this interaction means in plain words

Fenofibrate and Gliclazide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fenofibrate belongs to Cardiovascular; Gliclazide belongs to Endocrine.

Evidence level: Low

Why it happens

Additive glucose lowering and possible weak CYP2C9 inhibition or protein-binding displacement.

What to do

Monitor blood glucose when fenofibrate is started, especially in patients with low albumin. Reduce the gliclazide dose if hypoglycemia occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fenofibrate and Gliclazide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fenofibrate with Gliclazide?

MediHelp rates the interaction as minor. Fenofibrate and Gliclazide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fenofibrate improves insulin sensitivity and can modestly increase glucose lowering with sulfonylureas, with a possible risk of hypoglycemia. Fenofibrate also inhibits CYP2C9 in vitro, which could slightly increase gliclazide exposure.

How serious is the interaction between Fenofibrate and Gliclazide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when fenofibrate is started, especially in patients with low albumin. Reduce the gliclazide dose if hypoglycemia occurs.

What other medicines interact with Gliclazide?

MediHelp also lists interactions of Gliclazide with, for example, Ciprofloxacin, Clarithromycin, Disopyramide. The full list is on the Gliclazide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in